Impact BioMedical (IBO) shares fell 8% in recent Monday trading after the company made its debut on the NYSE American Market.
The stock was trading at $2.75 in recent trading, below the IPO price of $3.
Impact BioMedical said earlier in the day it priced the IPO of 1.5 million common shares at $3 per share.
The company said it granted the underwriters a 45-day option to buy an additional 225,000 shares.
The offering is expected to close on Tuesday, the company added.
Price: 2.75, Change: -0.25, Percent Change: -8.33